Biocryst Pharmaceuticals Stock Price History
| BCRX Stock | USD 8.31 0.23 2.69% |
Below is the normalized historical share price chart for BioCryst Pharmaceuticals extending back to March 04, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioCryst Pharmaceuticals stands at 8.31, as last reported on the 5th of March, with the highest price reaching 8.39 and the lowest price hitting 7.67 during the day.
If you're considering investing in BioCryst Stock, it is important to understand the factors that can impact its price. At this stage we consider BioCryst Stock to be somewhat reliable. BioCryst Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0476, which signifies that the company had a 0.0476 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for BioCryst Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm BioCryst Pharmaceuticals' Mean Deviation of 2.22, downside deviation of 3.22, and Risk Adjusted Performance of 0.0702 to double-check if the risk estimate we provide is consistent with the expected return of 0.14%.
At this time, BioCryst Pharmaceuticals' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 514.9 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (452.1 M). . Price Earnings To Growth Ratio is likely to rise to 0.29 in 2025, whereas Price To Sales Ratio is likely to drop 3.28 in 2025. BioCryst Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of March 1994 | 200 Day MA 7.5132 | 50 Day MA 8.0816 | Beta 1.847 |
BioCryst |
Sharpe Ratio = 0.0476
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | BCRX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.04 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average BioCryst Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioCryst Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 56.5858 | Enterprise Value Ebitda 177.258 | Price Sales 3.8527 | Shares Float 195.1 M | Wall Street Target Price 15.4167 |
BioCryst Pharmaceuticals Stock Price History Chart
There are several ways to analyze BioCryst Stock price data. The simplest method is using a basic BioCryst candlestick price chart, which shows BioCryst Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 19, 2025 | 9.39 |
| Lowest Price | January 16, 2025 | 7.06 |
BioCryst Pharmaceuticals March 5, 2025 Stock Price Synopsis
Various analyses of BioCryst Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioCryst Stock. It can be used to describe the percentage change in the price of BioCryst Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioCryst Stock.| BioCryst Pharmaceuticals Price Action Indicator | 0.17 | |
| BioCryst Pharmaceuticals Accumulation Distribution | 568,339 | |
| BioCryst Pharmaceuticals Price Daily Balance Of Power | (0.32) | |
| BioCryst Pharmaceuticals Price Rate Of Daily Change | 0.97 |
BioCryst Pharmaceuticals March 5, 2025 Stock Price Analysis
BioCryst Stock Price History Data
The price series of BioCryst Pharmaceuticals for the period between Thu, Dec 5, 2024 and Wed, Mar 5, 2025 has a statistical range of 2.33 with a coefficient of variation of 7.42. The prices are distributed with arithmetic mean of 7.96. The median price for the last 90 days is 7.83.| Open | High | Low | Close | Volume | ||
| 03/04/2025 | 8.14 | 8.39 | 7.67 | 8.31 | 6,622,729 | |
| 03/03/2025 | 8.58 | 8.80 | 8.45 | 8.54 | 4,851,882 | |
| 02/28/2025 | 8.46 | 8.66 | 8.41 | 8.61 | 4,230,228 | |
| 02/27/2025 | 8.36 | 8.67 | 8.28 | 8.47 | 4,430,582 | |
| 02/26/2025 | 8.32 | 8.57 | 8.15 | 8.36 | 3,416,407 | |
| 02/25/2025 | 8.44 | 8.44 | 7.94 | 8.28 | 3,672,512 | |
| 02/24/2025 | 8.87 | 8.96 | 7.95 | 8.29 | 6,078,362 | |
| 02/21/2025 | 9.50 | 9.50 | 9.15 | 9.21 | 5,555,579 | |
| 02/20/2025 | 9.39 | 9.50 | 9.29 | 9.39 | 3,415,368 | |
| 02/19/2025 | 9.34 | 9.48 | 9.31 | 9.39 | 4,826,716 | |
| 02/18/2025 | 9.10 | 9.45 | 9.09 | 9.36 | 5,333,059 | |
| 02/14/2025 | 8.83 | 9.11 | 8.72 | 9.05 | 5,148,611 | |
| 02/13/2025 | 8.87 | 8.90 | 8.63 | 8.82 | 3,654,225 | |
| 02/12/2025 | 8.91 | 9.00 | 8.72 | 8.78 | 2,516,997 | |
| 02/11/2025 | 8.57 | 9.00 | 8.54 | 8.99 | 3,116,235 | |
| 02/10/2025 | 8.69 | 8.80 | 8.53 | 8.63 | 1,813,616 | |
| 02/07/2025 | 8.74 | 8.87 | 8.59 | 8.72 | 2,340,286 | |
| 02/06/2025 | 8.64 | 8.87 | 8.49 | 8.73 | 3,177,587 | |
| 02/05/2025 | 8.16 | 9.00 | 8.15 | 8.61 | 3,721,595 | |
| 02/04/2025 | 7.59 | 8.13 | 7.57 | 8.09 | 2,370,866 | |
| 02/03/2025 | 7.72 | 7.73 | 7.54 | 7.62 | 2,184,768 | |
| 01/31/2025 | 7.86 | 8.04 | 7.82 | 7.90 | 1,861,865 | |
| 01/30/2025 | 8.08 | 8.14 | 7.80 | 7.87 | 2,221,776 | |
| 01/29/2025 | 7.92 | 8.10 | 7.85 | 8.02 | 1,850,230 | |
| 01/28/2025 | 8.01 | 8.07 | 7.90 | 7.93 | 1,747,828 | |
| 01/27/2025 | 7.60 | 8.09 | 7.53 | 8.01 | 3,109,428 | |
| 01/24/2025 | 7.64 | 7.85 | 7.55 | 7.64 | 2,197,248 | |
| 01/23/2025 | 7.58 | 7.75 | 7.45 | 7.73 | 2,861,091 | |
| 01/22/2025 | 7.59 | 7.67 | 7.46 | 7.62 | 1,829,473 | |
| 01/21/2025 | 7.50 | 7.79 | 7.41 | 7.61 | 3,125,231 | |
| 01/17/2025 | 7.04 | 7.49 | 6.96 | 7.45 | 3,964,020 | |
| 01/16/2025 | 7.21 | 7.28 | 6.98 | 7.06 | 2,519,104 | |
| 01/15/2025 | 7.45 | 7.47 | 7.16 | 7.23 | 2,365,796 | |
| 01/14/2025 | 7.97 | 8.02 | 7.22 | 7.23 | 2,529,179 | |
| 01/13/2025 | 7.77 | 8.00 | 7.54 | 7.93 | 2,690,683 | |
| 01/10/2025 | 8.49 | 8.49 | 7.53 | 7.67 | 4,743,967 | |
| 01/08/2025 | 8.11 | 8.29 | 7.99 | 8.05 | 2,145,456 | |
| 01/07/2025 | 7.83 | 8.23 | 7.80 | 8.14 | 1,747,511 | |
| 01/06/2025 | 7.64 | 8.07 | 7.64 | 7.83 | 1,629,746 | |
| 01/03/2025 | 7.87 | 8.02 | 7.69 | 7.70 | 1,267,149 | |
| 01/02/2025 | 7.59 | 8.10 | 7.48 | 7.83 | 3,106,778 | |
| 12/31/2024 | 7.60 | 7.70 | 7.46 | 7.52 | 1,513,767 | |
| 12/30/2024 | 7.65 | 7.71 | 7.48 | 7.53 | 1,448,179 | |
| 12/27/2024 | 7.65 | 7.79 | 7.59 | 7.71 | 998,329 | |
| 12/26/2024 | 7.65 | 7.83 | 7.62 | 7.72 | 1,240,701 | |
| 12/24/2024 | 7.73 | 7.84 | 7.60 | 7.67 | 753,880 | |
| 12/23/2024 | 7.57 | 7.82 | 7.38 | 7.78 | 1,523,751 | |
| 12/20/2024 | 7.25 | 7.60 | 7.25 | 7.57 | 5,070,885 | |
| 12/19/2024 | 7.34 | 7.48 | 7.22 | 7.39 | 2,017,592 | |
| 12/18/2024 | 7.47 | 7.59 | 7.15 | 7.31 | 2,341,868 | |
| 12/17/2024 | 7.23 | 7.62 | 7.20 | 7.49 | 1,560,506 | |
| 12/16/2024 | 7.41 | 7.54 | 7.21 | 7.46 | 2,605,868 | |
| 12/13/2024 | 7.56 | 7.63 | 7.44 | 7.53 | 1,597,453 | |
| 12/12/2024 | 7.83 | 7.90 | 7.58 | 7.60 | 1,440,018 | |
| 12/11/2024 | 7.90 | 8.07 | 7.83 | 7.86 | 1,466,209 | |
| 12/10/2024 | 7.75 | 8.00 | 7.68 | 7.93 | 1,770,377 | |
| 12/09/2024 | 7.60 | 7.80 | 7.55 | 7.73 | 1,434,081 | |
| 12/06/2024 | 7.89 | 8.16 | 7.60 | 7.61 | 1,687,057 | |
| 12/05/2024 | 7.39 | 7.93 | 7.34 | 7.84 | 2,770,578 | |
| 12/04/2024 | 7.20 | 7.56 | 7.11 | 7.33 | 1,805,207 | |
| 12/03/2024 | 7.32 | 7.43 | 7.14 | 7.19 | 1,883,666 |
About BioCryst Pharmaceuticals Stock history
BioCryst Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioCryst is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioCryst Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioCryst Pharmaceuticals stock prices may prove useful in developing a viable investing in BioCryst Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 206.7 M | 217 M | |
| Net Loss | -222.4 M | -211.3 M |
BioCryst Pharmaceuticals Quarterly Net Working Capital |
|
BioCryst Pharmaceuticals Stock Technical Analysis
BioCryst Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
BioCryst Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioCryst Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of BioCryst Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioCryst to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0702 | |||
| Jensen Alpha | 0.3154 | |||
| Total Risk Alpha | 0.589 | |||
| Sortino Ratio | 0.1016 | |||
| Treynor Ratio | 0.2762 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for BioCryst Stock Analysis
When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.